Uric acid — more than a gout number
Paired condition: Metabolic syndrome lab panel
Quick answer
Uric acid is the end product of purine breakdown. Its best-established role is in gout, where a serum target below 6 mg/dL guides treatment. Beyond gout, high uric acid travels closely with metabolic syndrome, high blood pressure, and insulin resistance — but whether it *causes* those problems or is mainly a marker of them is still debated, so it's read as a useful signal rather than a standalone treatment target in people without gout.
Reference ranges and interpretation
| Value / population | Classification | What it means |
|---|---|---|
| 3.5 – 7.2 mg/dL (men) | Typical | Standard adult male reference range. |
| 2.6 – 6.0 mg/dL (women) | Typical | Standard adult female reference range. |
| < 6 mg/dL | Gout treatment target | Standard serum-urate goal when treating gout (< 5 for severe/tophaceous). |
| > 7 mg/dL | Hyperuricemia | Above urate solubility; gout risk rises and metabolic associations strengthen. |
Above roughly 6.8 mg/dL, urate exceeds its solubility and can crystallize — the physical basis for the gout treatment target of < 6 mg/dL.
The gout number
Uric acid and metabolic health
What to check alongside uric acid
- Triglycerides + HDL — the lipid half of the metabolic pattern
- Blood pressure — hyperuricemia predicts incident hypertension
- eGFR / creatinine — the kidneys excrete most uric acid; reduced function raises it
- Diet and alcohol — purine-rich foods, alcohol (especially beer), and fructose all raise urate
Phi Longevity reads every marker on every lab you upload — together, against your history, against optimal ranges, and across time. The integrated picture tells you what a single number can't.
Start with my labs →Frequently asked questions
My uric acid is high but I've never had gout — do I need medication?
Generally no. Guidelines don't recommend urate-lowering drugs for asymptomatic hyperuricemia, because the evidence that lowering it prevents cardiovascular or kidney outcomes in people without gout is not established. It's better treated as a signal to address the metabolic pattern (diet, alcohol, insulin resistance) it usually travels with.
Why was my uric acid normal during a gout attack?
Serum urate can drop during an acute flare, so a normal level in the middle of an attack doesn't rule gout out. Clinicians typically remeasure a couple of weeks after the flare settles to get a representative value and to set a treatment target.
What raises uric acid?
Purine-rich foods (red meat, organ meats, some seafood), alcohol (beer especially), fructose-sweetened drinks, dehydration, certain diuretics, and reduced kidney function all raise uric acid. Insulin resistance also reduces urate excretion, which is part of why it clusters with metabolic syndrome.
What's the target if I'm being treated for gout?
The standard serum-urate target during urate-lowering therapy is below 6 mg/dL, and below 5 mg/dL for severe or tophaceous gout. Reaching and staying below target is what dissolves crystals and prevents future attacks — so treatment is guided by the number, checked periodically.
References
All citations verified against PubMed / publisher of record (see note below for this page's verification date).
- 1.FitzGerald JD, Dalbeth N, Mikuls T, et al. (2020). 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care & Research. 72(6):744-760. — Source for the serum-urate treatment targets (< 6 mg/dL; < 5 for severe/tophaceous) and treat-to-target approach.PubMed →DOI →
- 2.Dalbeth N, Merriman TR, Stamp LK. (2016). Gout. The Lancet. 388(10055):2039-2052. — Comprehensive seminar on urate biology, the solubility threshold, and gout pathophysiology.PubMed →DOI →
- 3.Feig DI, Kang DH, Johnson RJ. (2008). Uric acid and cardiovascular risk. New England Journal of Medicine. 359(17):1811-1821. — Reviews the association between uric acid and cardiovascular/metabolic risk and the unresolved causation question.PubMed →DOI →
Reference ranges vary by lab and assay. This page is educational and not a substitute for individualized medical advice; gout and hyperuricemia management should be guided by a clinician.
By Steve Pinedo
Co-founder, Phi Longevity
Last updated: 2026-07-20
Steve Pinedo is the Co-founder of Phi Longevity, the AI application that turns a confusing stack of lab reports, wearable data, and clinical notes into a single, integrated picture of your health. He started Phi Longevity to make proactive health and wellness far easier to achieve. He realized how difficult it was for clients to manage their own care, records and coordination so he assembled a comprehensive M.D. led clinical team behind the platform, packaging the proactive-care experience that delivered measurable outcomes (lower triglycerides, reduced body fat, improved LDL, balanced hormones, relief from long-running autoimmune conditions) for any patient with a complicated lab to use now with an application. More about Phi Longevity →